loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for cep_2017_160___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sanofi Winthrop Industrie Gentilly FR

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

CEP 2017-160 - Rev 01
Valid
Chemical
2024-02-14
2465
Sanofi Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Certificate Number : CEP 2017-160 - Rev 01

Status : Valid

Issue Date : 2024-02-14

Type : Chemical

Substance Number : 2465

Sanofi Company Banner

Looking for Certificates of Suitability (CEPs) for CEP 2017-160 - Rev 01 of Sanofi Winthrop Industrie Gentilly Fr

Looking for Certificates of Suitability (CEPs) for CEP 2017-160 - Rev 01 of Sanofi Winthrop Industrie Gentilly Fr 1

20

Sanofi Winthrop Industrie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their significant offerings is Irbesartan, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-160 - Rev 01

This Chemical Type CEP, issued on February 14, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2465 associated with this CEP further emphasizes